HIV therapies and the kidney: some good, some not so good?

Keyphrases

• Aging 33%
• Atazanavir 33%
• Chronic Kidney Disease 33%
• Clinical Impact 33%
• Clinical Symptoms 33%
• Drug Nephrotoxicity 33%
• HIV Treatment 100%
• HIV-positive 66%
• Independent Risk Factors 33%
• Indinavir 33%
• Kidney 100%
• Kidney Function 33%
• Kidney Impairment 33%
• Nephrotoxicity 33%
• Normal Renal Function 33%
• Plasma Drug Concentration 33%
• Randomized Trial 33%
• Renal Function 33%
• Ritonavir 33%
• Tenofovir 100%
• Urolithiasis 66%

Medicine and Dentistry

• Atazanavir 33%
• Chronic Kidney Disease 33%
• HIV Therapy 100%
• Human Immunodeficiency Virus 66%
• Indinavir 33%
• Kidney Function 100%
• Nephrotoxicity 66%
• Observational Study 33%
• Ritonavir 33%
• Symptom 33%
• Tenofovir 100%
• Urolithiasis 66%

Pharmacology, Toxicology and Pharmaceutical Science

• Atazanavir 33%
• Chronic Kidney Failure 33%
• Drug Concentration 33%
• HIV 66%
• HIV Therapy 100%
• Indinavir 33%
• Nephrotoxicity 66%
• Observational Study 33%
• Ritonavir 33%
• Symptom 33%
• Tenofovir 100%
• Urolithiasis 66%